Chica­go in­vestor de­vis­es £250M deal as re­al es­tate grows with UK's biotech sec­tor

Hav­ing snapped up a cov­et­ed spot at Kendall Square in Cam­bridge, MA for a re­port­ed $1 bil­lion last year, Chica­go-based re­al es­tate in­vestor Har­ri­son Street is eye­ing sev­er­al life sci­ences prop­er­ties in the UK.

Har­ri­son Street is part­ner­ing with Lon­don’s Trin­i­ty In­vest­ment Man­age­ment for the £250 mil­lion ($328 mil­lion) deal, which would give them joint own­er­ship of 1.6 mil­lion square feet of lab and of­fice space, mak­ing them land­lords of life sci­ences com­pa­nies such as GW Phar­ma­ceu­ti­cals, the Fi­nan­cial Times re­port­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.